These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 18089792)

  • 41. Effect of deguelin on UVB-induced skin carcinogenesis.
    Gills JJ; Kosmeder J; Moon RC; Lantvit DD; Pezzuto JM
    J Chemother; 2005 Jun; 17(3):297-301. PubMed ID: 16041863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer.
    Rödel F; Hoffmann J; Distel L; Herrmann M; Noisternig T; Papadopoulos T; Sauer R; Rödel C
    Cancer Res; 2005 Jun; 65(11):4881-7. PubMed ID: 15930309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apigenin, a chemopreventive bioflavonoid, induces AMP-activated protein kinase activation in human keratinocytes.
    Tong X; Smith KA; Pelling JC
    Mol Carcinog; 2012 Mar; 51(3):268-79. PubMed ID: 21538580
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AMP-activated protein kinase (AMPK) activation is involved in chrysin-induced growth inhibition and apoptosis in cultured A549 lung cancer cells.
    Shao JJ; Zhang AP; Qin W; Zheng L; Zhu YF; Chen X
    Biochem Biophys Res Commun; 2012 Jul; 423(3):448-53. PubMed ID: 22659738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of CAY10404 on the PKB/Akt and MAPK pathway and apoptosis in non-small cell lung cancer cells.
    Cho Y; Park MJ; Park M; Min SS; Yee J; Kim C; Han MS; Han SH
    Respirology; 2009 Aug; 14(6):850-8. PubMed ID: 19703066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.
    Huang Y; Hua K; Zhou X; Jin H; Chen X; Lu X; Yu Y; Zha X; Feng Y
    Cell Res; 2008 Jul; 18(7):780-91. PubMed ID: 18574502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhancement radiosensitization of breast cancer cells by deguelin.
    Yi T; Li H; Wang X; Wu Z
    Cancer Biother Radiopharm; 2008 Jun; 23(3):355-62. PubMed ID: 18593368
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A.
    Hino R; Uozaki H; Inoue Y; Shintani Y; Ushiku T; Sakatani T; Takada K; Fukayama M
    Cancer Res; 2008 Mar; 68(5):1427-35. PubMed ID: 18316606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cells.
    Hideshima T; Catley L; Raje N; Chauhan D; Podar K; Mitsiades C; Tai YT; Vallet S; Kiziltepe T; Ocio E; Ikeda H; Okawa Y; Hideshima H; Munshi NC; Yasui H; Richardson PG; Anderson KC
    Br J Haematol; 2007 Sep; 138(6):783-91. PubMed ID: 17760810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of AMP-activated protein kinase by kainic acid mediates brain-derived neurotrophic factor expression through a NF-kappaB dependent mechanism in C6 glioma cells.
    Yoon H; Oh YT; Lee JY; Choi JH; Lee JH; Baik HH; Kim SS; Choe W; Yoon KS; Ha J; Kang I
    Biochem Biophys Res Commun; 2008 Jul; 371(3):495-500. PubMed ID: 18445478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phosphatidylinositol-3-OH kinase/AKT and survivin pathways as critical targets for geranylgeranyltransferase I inhibitor-induced apoptosis.
    Dan HC; Jiang K; Coppola D; Hamilton A; Nicosia SV; Sebti SM; Cheng JQ
    Oncogene; 2004 Jan; 23(3):706-15. PubMed ID: 14737105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies.
    Tsao AS; McDonnell T; Lam S; Putnam JB; Bekele N; Hong WK; Kurie JM
    Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):660-4. PubMed ID: 12869408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sodium arsenite induces orphan nuclear receptor SHP gene expression via AMP-activated protein kinase to inhibit gluconeogenic enzyme gene expression.
    Chanda D; Kim SJ; Lee IK; Shong M; Choi HS
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E368-79. PubMed ID: 18505831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxidative stress induces GLUT4 translocation by activation of PI3-K/Akt and dual AMPK kinase in cardiac myocytes.
    Horie T; Ono K; Nagao K; Nishi H; Kinoshita M; Kawamura T; Wada H; Shimatsu A; Kita T; Hasegawa K
    J Cell Physiol; 2008 Jun; 215(3):733-42. PubMed ID: 18163380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.
    Chetoui N; Sylla K; Gagnon-Houde JV; Alcaide-Loridan C; Charron D; Al-Daccak R; Aoudjit F
    Mol Cancer Res; 2008 Jan; 6(1):42-52. PubMed ID: 18234961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Critical and diverse involvement of Akt/mammalian target of rapamycin signaling in human lung carcinomas.
    Dobashi Y; Suzuki S; Matsubara H; Kimura M; Endo S; Ooi A
    Cancer; 2009 Jan; 115(1):107-18. PubMed ID: 19090006
    [TBL] [Abstract][Full Text] [Related]  

  • 58. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer.
    Huang CL; Liu D; Nakano J; Yokomise H; Ueno M; Kadota K; Wada H
    Clin Cancer Res; 2007 Dec; 13(23):6938-46. PubMed ID: 18056168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy.
    Faried LS; Faried A; Kanuma T; Aoki H; Sano T; Nakazato T; Tamura T; Kuwano H; Minegishi T
    Mol Carcinog; 2008 Jun; 47(6):446-57. PubMed ID: 18058806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deguelin inhibits human hepatocellular carcinoma by antiangiogenesis and apoptosis.
    Lee JH; Lee DH; Lee HS; Choi JS; Kim KW; Hong SS
    Oncol Rep; 2008 Jul; 20(1):129-34. PubMed ID: 18575727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.